Compare Stocks: HYPR, TLSI, RCEL, and TMCI

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
HYPR Hyperfine	$0.81 -2.8%	$0.99	$0.79 ▼ $2.22	$88.76M	1.41	557,228 shs	524,504 shs
RCEL Avita Medical	$11.20 +2.4%	$6.71	$3.22 ▼ $11.39	$336.70M	2.02	803,239 shs	301,600 shs
TLSI TriSalus Life Sciences	$5.00 +0.4%	$4.74	$2.20 ▼ $7.95	$306.64M	0.44	165,547 shs	86,870 shs
TMCI Treace Medical Concepts	$4.81 -1.4%	$4.45	$1.17 ▼ $7.63	$317.37M	1.4	372,022 shs	231,832 shs

10 Best Stocks to Own - Summer 2026

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
HYPR Hyperfine	+3.85%	-0.99%	-17.94%	-39.35%	-25.27%
RCEL Avita Medical	+1.67%	+6.01%	+136.29%	+161.72%	+155.01%
TLSI TriSalus Life Sciences	-3.11%	+1.01%	+5.06%	+57.10%	0.00%
TMCI Treace Medical Concepts	+3.83%	+6.09%	+2.95%	+39.03%	-32.69%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
HYPR Hyperfine	$0.81 -2.8%	$0.99	$0.79 ▼ $2.22	$88.76M	1.41	557,228 shs	524,504 shs
RCEL Avita Medical	$11.20 +2.4%	$6.71	$3.22 ▼ $11.39	$336.70M	2.02	803,239 shs	301,600 shs
TLSI TriSalus Life Sciences	$5.00 +0.4%	$4.74	$2.20 ▼ $7.95	$306.64M	0.44	165,547 shs	86,870 shs
TMCI Treace Medical Concepts	$4.81 -1.4%	$4.45	$1.17 ▼ $7.63	$317.37M	1.4	372,022 shs	231,832 shs

10 Best Stocks to Own - Summer 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
HYPR Hyperfine	+3.85%	-0.99%	-17.94%	-39.35%	-25.27%
RCEL Avita Medical	+1.67%	+6.01%	+136.29%	+161.72%	+155.01%
TLSI TriSalus Life Sciences	-3.11%	+1.01%	+5.06%	+57.10%	0.00%
TMCI Treace Medical Concepts	+3.83%	+6.09%	+2.95%	+39.03%	-32.69%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
HYPR Hyperfine	2.40	Hold	$2.03	150.01% Upside
RCEL Avita Medical	2.57	Moderate Buy	$11.40	1.79% Upside
TLSI TriSalus Life Sciences	2.25	Hold	$7.50	50.00% Upside
TMCI Treace Medical Concepts	1.86	Reduce	$5.17	7.48% Upside

Current Analyst Ratings Breakdown

Latest HYPR, TLSI, RCEL, and TMCI Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/31/2026	TMCI Treace Medical Concepts	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
8/28/2026	RCEL Avita Medical	Lake Street Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$8.00 ➝ $12.00
8/20/2026	HYPR Hyperfine	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$2.00
8/19/2026	RCEL Avita Medical	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$12.00 ➝ $14.00
8/19/2026	RCEL Avita Medical	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$7.00 ➝ $11.00
8/14/2026	TMCI Treace Medical Concepts	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/10/2026	HYPR Hyperfine	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$2.00 ➝ $1.60
8/10/2026	TMCI Treace Medical Concepts	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Hold	$4.00 ➝ $5.00
8/7/2026	TLSI TriSalus Life Sciences	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
8/7/2026	RCEL Avita Medical	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$7.00
7/17/2026	HYPR Hyperfine	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)

(Data available from 9/4/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
HYPR Hyperfine	$11.40M	7.57	N/A	N/A	$0.35 per share	2.32
RCEL Avita Medical	$71.61M	4.81	N/A	N/A	($0.90) per share	-12.44
TLSI TriSalus Life Sciences	$45.15M	6.82	N/A	N/A	$0.11 per share	45.45
TMCI Treace Medical Concepts	$212.69M	1.47	N/A	N/A	$1.04 per share	4.63

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
HYPR Hyperfine	-$35.57M	-$0.38	N/A	N/A	N/A	-210.75%	-97.88%	-61.81%	11/12/2026 (Estimated)
RCEL Avita Medical	-$48.59M	-$1.44	N/A	N/A	N/A	-56.96%	N/A	-78.53%	11/5/2026 (Estimated)
TLSI TriSalus Life Sciences	-$39.23M	-$1.30	N/A	N/A	N/A	-62.59%	N/A	-64.47%	11/12/2026 (Estimated)
TMCI Treace Medical Concepts	-$59M	-$0.93	N/A	N/A	N/A	-28.99%	-71.37%	-30.49%	11/5/2026 (Estimated)

Latest HYPR, TLSI, RCEL, and TMCI Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/7/2026	Q2 2026	TMCI Treace Medical Concepts	-$0.2980	-$0.24	+$0.0580	-$0.24	$44.02 million	$45.38 million
8/6/2026	Q2 2026	HYPR Hyperfine	-$0.09	-$0.09	N/A	-$0.09	$4.14 million	$3.90 million
8/6/2026	Q2 2026	RCEL Avita Medical	-$0.2928	-$0.25	+$0.0428	-$5.00	$20.25 million	$21.70 million
8/6/2026	Q2 2026	TLSI TriSalus Life Sciences	-$0.1550	-$0.16	-$0.0050	-$0.16	$10.27 million	$11.41 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
HYPR Hyperfine	N/A	N/A	N/A	N/A	N/A
RCEL Avita Medical	N/A	N/A	N/A	N/A	N/A
TLSI TriSalus Life Sciences	N/A	N/A	N/A	N/A	N/A
TMCI Treace Medical Concepts	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
HYPR Hyperfine	0.36	6.15	5.45
RCEL Avita Medical	N/A	0.41	0.34
TLSI TriSalus Life Sciences	5.05	5.35	4.97
TMCI Treace Medical Concepts	0.83	2.90	1.95

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
HYPR Hyperfine	15.03%
RCEL Avita Medical	27.66%
TLSI TriSalus Life Sciences	2.58%
TMCI Treace Medical Concepts	84.08%

Insider Ownership

Company	Insider Ownership
HYPR Hyperfine	26.33%
RCEL Avita Medical	2.24%
TLSI TriSalus Life Sciences	16.30%
TMCI Treace Medical Concepts	23.42%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
HYPR Hyperfine	190	106.05 million	78.13 million	Optionable
RCEL Avita Medical	130	30.78 million	30.09 million	Optionable
TLSI TriSalus Life Sciences	106	61.58 million	51.54 million	Not Optionable
TMCI Treace Medical Concepts	250	65.04 million	49.80 million	Optionable

HYPR, TLSI, RCEL, and TMCI Headlines

Recent News About These Companies

Bank of America Corp DE Has $4.31 Million Stock Holdings in Treace Medical Concepts, Inc. $TMCI

August 29, 2026 | marketbeat.com

Treace Medical Concepts (NASDAQ:TMCI) CEO John Treace Buys 5,000 Shares

August 25, 2026 | insidertrades.com

John Treace Acquires 5,000 Shares of Treace Medical Concepts (NASDAQ:TMCI) Stock

August 24, 2026 | marketbeat.com

Insider Buying: Treace Medical Concepts (NASDAQ:TMCI) CEO Acquires 11,000 Shares

August 24, 2026 | marketbeat.com

Treace Medical Concepts (NASDAQ:TMCI) CEO John Treace Acquires 39,944 Shares of Stock

August 24, 2026 | marketbeat.com

Weber Capital Management LLC ADV Takes $2.35 Billion Position in Treace Medical Concepts, Inc. $TMCI

August 24, 2026 | marketbeat.com

Treace Medical Concepts Earnings Call Signals Cautious Rebound

August 18, 2026 | tipranks.com

522,900 Shares in Treace Medical Concepts, Inc. $TMCI Purchased by Renaissance Technologies LLC

August 17, 2026 | marketbeat.com

Treace Medical (TMCI) Q2 2026 Earnings Call Transcript

August 14, 2026 | finance.yahoo.com

Treace Medical Concepts, Inc. (NASDAQ:TMCI) Given Consensus Rating of "Reduce" by Analysts

August 11, 2026 | marketbeat.com

Treace Medical Concepts (NASDAQ:TMCI) Price Target Raised to $5.00 at Truist Financial

August 10, 2026 | marketbeat.com

Treace Medical Concepts, Inc. Q2 2026 Earnings Call Summary

August 8, 2026 | finance.yahoo.com

Treace Medical Concepts (NASDAQ:TMCI) Posts Quarterly Earnings Results, Beats Estimates By $0.06 EPS

August 7, 2026 | marketbeat.com

Treace Medical Concepts: Q2 Earnings Snapshot

August 7, 2026 | seattlepi.comS

Treace Medical Concepts, Inc. (TMCI) Q2 2026 Earnings Call Transcript

August 7, 2026 | seekingalpha.com

Treace Medical Concepts Q2 Earnings Call Highlights

August 7, 2026 | marketbeat.com

Treace Medical Concepts (TMCI) Reports Q2 Loss, Tops Revenue Estimates

August 7, 2026 | zacks.com

Treace Medical Concepts Reports Second Quarter 2026 Financial Results

August 7, 2026 | globenewswire.com

Did Treace Medical Concepts, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

July 24, 2026 | prnewswire.com

Treace to Report Second Quarter 2026 Financial Results on August 7, 2026

July 24, 2026 | globenewswire.com

Why Treace Medical Concepts, Inc.’s (TMCI) Stock Is Down 5.42%

July 23, 2026 | aaii.comA

New MarketBeat Followers Over Time

Media Sentiment Over Time

HYPR, TLSI, RCEL, and TMCI Company Descriptions

Hyperfine NASDAQ:HYPR

$0.81 -0.02 (-2.83%)

As of 04:00 PM Eastern

Hyperfine, Inc., a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors. Hyperfine, Inc. was founded in 2014 and is based in Guilford, Connecticut.

Avita Medical NASDAQ:RCEL

$11.20 +0.26 (+2.38%)

As of 04:00 PM Eastern

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.

TriSalus Life Sciences NASDAQ:TLSI

$5.00 +0.02 (+0.40%)

As of 04:00 PM Eastern

TriSalus Life Sciences, Inc., a medical technology company, researches, develops, and sells drug delivery technologies and immune-oncology therapeutics for the treatment of liver and pancreatic cancer. The company offers Pressure Enabled Drug Delivery infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases; and the Pancreatic Retrograde Venous Infusion device, which is in Phase 1 clinical trial, for locally advanced pancreatic cancer. It also develops nelitolimod, an investigational immunotherapeutic in Phase 1 clinical trial for the treatment of uveal melanoma with liver metastases, hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and locally advanced pancreatic ductal adenocarcinoma. The company serves interventional radiologists, IR technicians, medical oncologists, nursing support, value analysis committee staff, and patients through its sales representatives and sales managers. TriSalus Life Sciences, Inc. was founded in 2009 and is headquartered in Westminster, Colorado.

Treace Medical Concepts NASDAQ:TMCI

$4.81 -0.07 (-1.43%)

As of 04:00 PM Eastern

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest HYPR, TLSI, RCEL, and TMCI Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest HYPR, TLSI, RCEL, and TMCI Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

HYPR, TLSI, RCEL, and TMCI Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

HYPR, TLSI, RCEL, and TMCI Company Descriptions

Hyperfine NASDAQ:HYPR

Avita Medical NASDAQ:RCEL

TriSalus Life Sciences NASDAQ:TLSI

Treace Medical Concepts NASDAQ:TMCI

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest HYPR, TLSI, RCEL, and TMCI Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest HYPR, TLSI, RCEL, and TMCI Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

HYPR, TLSI, RCEL, and TMCI Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

HYPR, TLSI, RCEL, and TMCI Company Descriptions

Hyperfine NASDAQ:HYPR

Avita Medical NASDAQ:RCEL

TriSalus Life Sciences NASDAQ:TLSI

Treace Medical Concepts NASDAQ:TMCI

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools